EyePoint Pharmaceuticals (EYPT) P/E (2010 - 2026)
EyePoint Pharmaceuticals (EYPT) P/E from Sep 30, 2010 to Jul 21, 2026. The TTM EyePoint Pharmaceuticals (EYPT) P/E is -3.67. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of EyePoint Pharmaceuticals (EYPT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.67 | -35.80% |
| 2025 | -5.72 | +79.11% |
| 2024 | -3.19 | -59.69% |
| 2023 | -7.92 | +420.61% |
| 2022 | -1.52 | -76.02% |
| 2021 | -6.35 | +211.76% |
| 2020 | -2.04 | -27.82% |
| 2019 | -2.82 | +58.62% |
| 2018 | -1.78 | +8.31% |
| 2017 | -1.64 | -73.51% |
| 2016 | -6.20 | -11.55% |
| 2015 | -7.01 | -160.08% |
| 2014 | 11.66 | -263.23% |
| 2013 | -7.15 | +602.78% |
| 2012 | -1.02 | -61.96% |
| 2011 | -2.67 | -83.52% |
| 2010 | -16.22 | N/A |
Comparison EyePoint Pharmaceuticals (EYPT) P/E with competitors
EyePoint Pharmaceuticals (EYPT) P/E is -3.67.